Immunology. An antibody paradox, resolved.
Prlic
Martin
M
Department of Immunology and the Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195-7370, USA. mprlic@u.washington.edu
Bevan
Michael J
MJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000936:Antigen-Antibody Complex / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D049109:Cell Proliferation; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007156:Immunologic Memory; D019409:Interleukin-15 / Q000276:immunology; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D011961:Receptors, Fc / Q000276:immunology / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000378:metabolism*; D016176:T-Lymphocyte Subsets / Q000166:cytology / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D019409:Interleukin-15; D007376:Interleukin-2; D011961:Receptors, Fc; D015375:Receptors, Interleukin-2